SYNNOVATION THERAPEUTICS, INC. — Form D

SYNNOVATION THERAPEUTICS, INC. of WILMINGTON, DE, a company, filed a Form D exempt-offering notice with the SEC on 2023-05-24. The offering totals $25.0M, of which $25.0M was reported sold. Industry: Biotechnology.

Offering

Filed: 2023-05-24
Form: D
Accession: 0001889137-23-000002
Industry: Biotechnology
Exemptions: 06b
Total offering: $25.0M
Amount sold: $25.0M
Investors: 4
Date of first sale: 2023-05-17
Security types: equity
Revenue range: Decline to Disclose
SEC file number: 021-482506

Issuer

Name: SYNNOVATION THERAPEUTICS, INC.
CIK: 0001889137
Entity type: Corporation
Jurisdiction: DELAWARE
Incorporated: 2021
Address: 200 POWDER MILL ROAD, WILMINGTON, DE, 19803
Phone: 302-521-9490

Officers, directors & promoters (6)

Name	Role	Location
Reid Huber	Director	Boston, MA
Liangxing Wu	Director	Wilmington, DE
Liangxing Wu	Executive Officer	Wilmington, DE
Wenqing Yao	Director	Wilmington, DE
Wenqing Yao	Executive Officer	Wilmington, DE
Ting Feng	Director	Wilmington, DE

Other filings by this issuer (3)

Filed	Form	Offering	Sold
2023-12-21	D/A	$102.5M	$15.0M
2023-12-14	D	$102.5M	$69.9M
2021-11-26	D	$20.0M	$12.0M

More